Meningioma 1 Antikörper (Middle Region)
Kurzübersicht für Meningioma 1 Antikörper (Middle Region) (ABIN953469)
Target
Alle Meningioma 1 (MN1) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 842-872, Middle Region
-
Spezifität
- This antibody recognizes Human MN1 (Center).
-
Aufreinigung
- Protein A column, followed by peptide affinity purification
-
Immunogen
- KLH conjugated synthetic peptide between 842-872 amino acids from the Central region of human MN1.
-
Isotyp
- Ig Fraction
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.25 mg/mL
-
Buffer
- PBS containing 0.09 % (W/V) Sodium Azide as preservative
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- Meningioma 1 (MN1) (MN1 proto-oncogene (MN1))
-
Andere Bezeichnung
- MN1
-
Hintergrund
- Meningioma 1 (MN1) contains two sets of CAG repeats. It is disrupted by a balanced translocation (4,22) in a meningioma, and its inactivation may contribute to meningioma 32 pathogenesis.Synonyms: Probable tumor suppressor protein MN1, meningioma 1
-
Molekulargewicht
- 136001 Da
-
Gen-ID
- 4330
-
NCBI Accession
- NP_002421
Target
-